SMHI SEACOR beats earnings estimates by 35 but revenue slides 16 shares fall despite results CHS B Pref 3 CHSCM Stock Risk Exposure Flirts with Support 20260416 Fulcrum Therapeutics FULC narrows Q1 loss 18 more than expected despite zero revenue shares rise 2 BIOA BioAge Labs Inc Q4 2025 loss narrows more than expected shares climb 883 percent on investor enthusiasm FMAO Q1 2026 Earnings EPS Surpasses Estimates Amidst Challenging Interest Rate Environment MMLP Q1 2026 Earnings Partnership Reports Loss as Stock Declines Cresud CRESY Q1 2026 Earnings Strong EPS Report Despite Modest Stock Decline VEEV Q1 2026 Earnings EPS Beat Drives Modest Stock Gain Amid Steady Execution NTGR Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Lower JANX Q1 2026 Earnings NarrowerthanExpected Loss Buoys Biotech Sentiment